一种新的预后指数所确定的临床类别反映了早期慢性淋巴细胞白血病患者的生物学特征：意大利淋巴瘤研究组（GISL）的经验。 - Suppr | 超能文献

Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience.

作者信息

Molica Stefano, Di Raimondo Francesco, Cutrona Giovanna, Fabris Sonia, Mauro Francesca, Brugiatelli Maura, Baldini Luca, Musto Pellegrino, Sacchi Stefano, Cortelezzi Agostino, Foà Robert, Neri Antonino, Federico Massimo, Ferrarini Manlio, Morabito Fortunato

出版信息

Leuk Res. 2010 Aug;34(8):e217-8. doi: 10.1016/j.leukres.2010.03.014. Epub 2010 Mar 31.

DOI:10.1016/j.leukres.2010.03.014

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience.一种新的预后指数所确定的临床类别反映了早期慢性淋巴细胞白血病患者的生物学特征：意大利淋巴瘤研究组（GISL）的经验。

Leuk Res. 2010 Aug;34(8):e217-8. doi: 10.1016/j.leukres.2010.03.014. Epub 2010 Mar 31.

2

Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.工作分类A组低度非霍奇金淋巴瘤国际预后指数的验证：来自意大利淋巴瘤研究组登记处137例患者的回顾性分析

Haematologica. 2000 Feb;85(2):154-9.

3

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).36例成年原发性间变性大细胞淋巴瘤患者的临床特征、治疗结果及生存情况。意大利淋巴瘤研究组（GISL）。

Haematologica. 1999 May;84(5):425-30.

4

Prognosis in chronic lymphocytic leukemia (CLL): experience of the Italian cooperative group (GIMEMA).慢性淋巴细胞白血病（CLL）的预后：意大利协作组（GIMEMA）的经验

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:162-4.

5

Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?B 细胞慢性淋巴细胞白血病生物学变量的预后价值。我们能否改进临床参数？

Haematologica. 1997 Nov-Dec;82(6):705-9.

6

Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy.惰性非滤泡性非霍奇金淋巴瘤的前瞻性研究：意大利淋巴瘤研究组（GISL）观察等待策略预后标准的验证

Leuk Lymphoma. 2002 Oct;43(10):1933-8. doi: 10.1080/1042819021000016050.

7

Chronic lymphocytic leukemia.慢性淋巴细胞白血病

Crit Rev Oncol Hematol. 2007 Dec;64(3):234-46. doi: 10.1016/j.critrevonc.2007.04.008. Epub 2007 Jun 1.

8

Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.慢性淋巴细胞白血病：新的预后因素及其与风险适应性治疗策略的相关性。

Haematologica. 2005 Mar;90(3):391-9.

9

Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia.细胞遗传学和分子预后标志物对慢性淋巴细胞白血病临床管理的影响

Haematologica. 2008 Jan;93(1):14-9. doi: 10.3324/haematol.12319.

10

Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL).套细胞淋巴瘤的回顾性分析：“意大利淋巴瘤研究组”（GISL）的经验

Haematologica. 1998 Nov;83(11):993-7.

引用本文的文献

1

Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.成人新诊断慢性淋巴细胞白血病的预后模型：一项系统评价和荟萃分析。

Cochrane Database Syst Rev. 2020 Jul 31;7(7):CD012022. doi: 10.1002/14651858.CD012022.pub2.

2

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.IGHV 基因突变状态和 17p 缺失是慢性淋巴细胞白血病总生存预测综合临床生物学预后模型中的独立分子预测因子。

J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18.